Medigen Vaccine Biologics : Announcement of the company's cash capital increase subscription date and other related matters

Close

Today's Information

Provided by: Medigen Vaccine Biologics Corporation
SEQ_NO	2	Date of announcement	2022/04/13	Time of announcement	18:28:42
Subject	Announcement of the company's cash capital increase subscription date and other related matters
Date of events	2022/04/13	To which item it meets	paragraph 11
Statement	1.Date of the board of directors resolution or decision by the Company for record date:2022/04/13 2.Whether to adopt shelf registration (Yes, please state issuance period /No): No 3.Effective registration date approved by competent authority:2022/04/12 4.Date of the board of directors resolution for (additional) issuance of shares:2022/03/01 5.Total monetary value of the issuance and number of shares issued: The total amount NT$70,000,000 / 7,000,000 shares outstanding 6.If adopting shelf registration, monetary value and number of shares to be issued this time:NA 7.The remaining monetary value and shares after this issuance when adopting shelf registration:NA 8.Par Value per share:NT$10 9.Issue price:To be announced after pricing 10.Number of shares subscribed for by employees: In accordance with Article 267 of the Companies Act, 10% (700,000 shares) of the total number of new shares to be issued are reserved for subscription by employees of the Company. 11.Ratio of shares subscribed for by existing shareholders: 80% (5,600,000 shares) is subscribed by the original shareholders in proportion to the shareholders' shareholding as recorded in the register of shareholders on the basis date of the capital increase. 12.Method for public sale and no.of shares: Pursuant to Article 28-1 of the Securities and Exchange Act,10% (700,000 shares) of the total amount of new shares issued are allocated for public underwriting. 13.Handling method for fractional shares and shares unsubscripted for by the deadline: For the subscription of less than one share of abnormally zero shares, the shareholder shall go to the Company's stock agency to apply for a whole share subscription within five days from the date of suspension of transfer. The original shareholders and employees waived the subscription or obbled together the abnormal fractional share of less than one share, and authorized the chairman to negotiate a specific person to offtake at the issue price. 14.Rights and obligations of these newly issued shares: The same as the original issued shares. 15.Utilization of the funds from the current capital increase: Enrichment of working capital 16.Record date of cash capital increase and share subscription:2022/05/06 17.Last date before book closure:2022/05/01 18.Book closure starting date:2022/05/02 19.Book closure ending date:2022/05/06 20.Payment period:2022/05/10~2022/06/10 21.Date of the agreement with the banks to collect and deposit the proceeds: Announcement to be made after contract execution. 22.Name of the institution designated to collect the proceeds: Announcement to be made after contract execution. 23.Name of the bank designated to deposit the proceeds: Announcement to be made after contract execution. 24.Any other matters that need to be specified: (1)The Company's declaration of the 2022 cash capital increase to issue 7,000,000 ordinary shares was declared to take effect by letter No.1110335738 of the Financial Supervisory Commission on April 12, 2022. (2)The important contents of the cash capital increase plan .Calculations may produce benefits and other related matters, such as changes in laws and regulations, amendments by competent authorities, changes in the objective environment or causes. When it is necessary to amend or adjust in response to the needs of the subjective and objective environment, it is proposed to authorize the chairman of the board of directors to handle the amendment or adjustment with full authority.